期刊文献+

Fabry病临床报告及病理学研究 被引量:2

Clinical report and pathological study of Fabry disease
下载PDF
导出
摘要 目的探讨Fabry病的临床特点及其病理学特征。方法通过1例Fabry病患者详细的临床资料,检索国内外相关资料,研究Fabry病的发病机制、临床特征、治疗及预后。结果典型的临床表现结合特征性病理改变可诊断Fabry病。结论Fabry病为罕见的代谢性遗传性疾病,加强对该病的认识,减少误诊,加强产前诊断可降低本病的发生率。 Objective To investigative clinical and pathological features of Fabry disease. Methods According to detailed clinical data of a patient with Fabry disease and related data in home and abroad, authors studied the pathogenic mechanism, clinical feature, therapy and prognosis of the disease. Results Diagnosis of Fabry disease might be depended on typical clinical manifestations and characteristic pathological changes. Conclusion Fabry disease is a uncommon metabolic genetic disease. The misdiagnosis can reduce if reinforcing the cognizance of the Fabry disease, and the incidence rate will reduce by fortifying prenatal diagnosis.
机构地区 南通市瑞慈医院
出处 《临床心身疾病杂志》 CAS 2005年第4期295-298,共4页 Journal of Clinical Psychosomatic Diseases
关键词 FABRY病 血管角质瘤 Α-半乳糖苷酶 Fabry disease angiokeratoma a-galactosidase
  • 相关文献

参考文献12

  • 1Fabry J. Ein Beitragzur kenntnisder Purpura haemorrhargica nodularis (Purpura papulosa haemorrhagic hebrae)[J]. Arch Dermatol Syphilis, 1898,43:187
  • 2Anderson WA. A case of angiokeratoma[J]. Br J Dermatol,1898,18:113
  • 3MacDermor KD, Holmes A,Miners AH. Anderson-Fabry disease: Clinical manifestations and inpact of disease in a cohort of 98 hemizygous males [J]. J Med Genet, 2001,38:750
  • 4Peters FPJ, Vermeulen A, Kho TL. Anderson-Fabrys disease: alphagalctosidase deficiency [J]. Lancet, 2001,357:138
  • 5Germain DP. Fabry disease clinical and genetic aspects:therapeutic perspectives[J]. Rev Med Interne, 2000,21:1086
  • 6Meikle PJ, Hopwood JJ,Clague AE. Pervalence of lysosomal storage disorders[J]. JAMA, 1999,281:249
  • 7吕冰清.Fabry′s病[J].国外医学(神经病学.神经外科学分册),1989,16(1):35-37. 被引量:3
  • 8Abe A,Arend LJ. Glycosphingolipid depletion in Fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase[J]. Kidney Int, 2000,57: 446
  • 9Lao LM,Kumakiri M,Mima H,et al. The ultrastructural characteristics or eccrine sweat glands in a Fabry disease patient with hypohidrosis [J]. J Dermatol Sci,1998,109
  • 10Meroni M, Sessa A, Battini G, et al. Kidney involvement in Anderson-Fabry disease[J]. Contrib Nephrol, 1997,122:178

二级参考文献2

  • 1A. Ejiofor,D. Robinson,D. Wise,M. Hamers,J. M. Tager. Anderson-fabry disease: Rapid detection of carriers by hair bulb analysis[J] 1978,Journal of Inherited Metabolic Disease(2):71~74
  • 2F. M. S. Tomé,M. Fardeau,G. Lenoir. Ultrastructure of muscle and sensory nerve in Fabry’s disease[J] 1977,Acta Neuropathologica(3):187~194

共引文献2

同被引文献34

  • 1张苏华,尹广.Fabry病及其酶替代疗法[J].肾脏病与透析肾移植杂志,2004,13(6):560-565. 被引量:9
  • 2曲利娟,郑智勇,余英豪,刘庆宏,曾玲.Fabry病1例报道并文献复习[J].诊断病理学杂志,2005,12(1):52-54. 被引量:4
  • 3李文歌.Fabry病的肾脏病变及诊治进展[J].中国医师进修杂志(内科版),2006,29(6):8-10. 被引量:4
  • 4[2]Beck M,Whybra C,Wendrich K,et al.AndersonFabry disease in children and adolescents[J].Contrib Nephrol,2001,136:251-255.
  • 5[3]Blaydon D,Hill J,Winchester B.Fabry disease:20novel GLA mutations in 35 families[J].Hum Mutat,2001,18:459-459.
  • 6[4]Whybra C,Wendrich K,Ries M,et al.Clinical manifestation in female Fabry disease patients[J].Contrib Nephrol,2001,136:245-250.
  • 7[5]Breunig F,Weidemann F,Beer M,et al.Fabry disease:diagnosis and treatment[J].Kidney Int Suppl,2003,84:181-185.
  • 8[7]Masson C,Cisse I,Simon V,et al.Fabry disease:a review[J].Joint Bone Spine,2004,71:381-383.
  • 9[8]Abe A,Arend LJ.GlycOsphingOJipid depletion in Fabry disease lymphoblasts with potent inhibitors of glucosylce ramide synthase[J].Kidney Int,2000,57:446-454.
  • 10[9]Lno LM,Kumakiri M,Mima H,et al.The ultrastructural characteristics or eecrine sweat glands in a Fabry disease patient with hypohidrosis[J].Dermatol Sci,1998,18:109-117.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部